WSC
BIIB icon

Wellington Shields & Co’s Biogen BIIB Stock Holding History

Wellington Shields & Co’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100
Closed -$23.2K – 312
2024
Q2 		$23.2K Hold
100
– – 0.01% 293
2024
Q1 		$21.6K Hold
100
– – 0.01% 293
2023
Q4 		$25.9K Hold
100
– – 0.01% 280
2023
Q3 		$25.7K Sell
100
-50
-33% -$13.4K 0.01% 274
2023
Q2 		$42.7K Hold
150
– – 0.01% 268
2023
Q1 		$41.7K Hold
150
– – 0.01% 275
2022
Q4 		$41.5K Hold
150
– – 0.01% 269
2022
Q3 		$40K Hold
150
– – 0.02% 253
2022
Q2 		$31K Buy
+150
New +$30.7K 0.01% 265

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Shields & Co's BIIB Position: Q3 2024 in Review

Wellington Shields & Co sold out of Biogen (BIIB) in Q3 2024, closing a stake of 100 shares — an estimated $23.2K sold.

Wellington Shields & Co first reported a position in BIIB in Q2 2022 and held it in 9 quarters. The position peaked at $42.7K in Q2 2023. 917 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

  • Wellington Shields & Co reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
  • Wellington Shields & Co sold 100 Biogen shares in Q3 2024, an estimated $23.2K.
  • Wellington Shields & Co first reported a position in Biogen in Q2 2022 and held it in 9 quarters.
  • Wellington Shields & Co's Biogen position peaked at $42.7K in Q2 2023.
  • 917 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Wellington Shields & Co's 13F filing for Q3 2024, filed 13 Nov 2024.